BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2170006)

  • 1. Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer.
    Leonard RC; Duncan LW; Hay FG
    Cancer Res; 1990 Oct; 50(20):6545-8. PubMed ID: 2170006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
    Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
    Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow metastases detection in small cell lung cancer. A review.
    Trillet-Lenoir VN; Arpin D; Brune J
    Anticancer Res; 1994; 14(6B):2795-7. PubMed ID: 7872720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of small cell lung cancer bone marrow metastases by immunofluorescence.
    Humblet Y; Canon JL; Sekhavat M; Feyens AM; Manouvriez P; Lebacq-Verheyden AM; Bazin H; Prignot J; Symann M
    Pathol Biol (Paris); 1988 Jan; 36(1):25-8. PubMed ID: 2834687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
    Fujisawa M; Okabe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation.
    Hunter RF; Broadway P; Sun SL; Niell HB; Mauer AM
    Cancer Res; 1987 May; 47(10):2737-40. PubMed ID: 3032414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines.
    Gordon LI; Rosen ST; Vriesendorp HM; Kies MS; Kucuk O
    Cancer Res; 1984 Nov; 44(11):5404-8. PubMed ID: 6091877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artifactual distortion of cells simulating metastatic small cell carcinoma in the bone marrow.
    Cartagena N; Suster S; Cabello-Inchausti B
    Ann Clin Lab Sci; 1993; 23(2):130-6. PubMed ID: 8384430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
    Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
    Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
    Elias AD; Pap SA; Bernal SD
    Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods.
    Beiske K; Myklebust AT; Aamdal S; Langholm R; Jakobsen E; Fodstad O
    Am J Pathol; 1992 Sep; 141(3):531-8. PubMed ID: 1381558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of small cell lung cancer bone marrow metastases by tumor stem cell assay.
    Humblet Y; Symann M
    Pathol Biol (Paris); 1988 Jan; 36(1):83-5. PubMed ID: 2834689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support.
    Vredenburgh JJ; Silva O; Broadwater G; Berry D; DeSombre K; Tyer C; Petros WP; Peters WP; Bast RC
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):91-7. PubMed ID: 9267669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC).
    Hay FG; Ford A; Leonard RC
    Int J Cancer Suppl; 1988; 2():8-10. PubMed ID: 2832333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biological aspects of intensive chemotherapy with autologous bone marrow grafts in small-cell bronchial cancer].
    Symann M; Humblet Y; Bosly A
    Bull Mem Acad R Med Belg; 1989; 144(3-4):213-21; discussion 222-3. PubMed ID: 2553180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 'small cell carcinoma antigens' in primary small cell lung cancer and metastases: an immunohistochemical study.
    Skov BG; Hirsch FR; Hay FG; Olsen JE; Bobrow LG
    Br J Cancer Suppl; 1991 Jun; 14():46-8. PubMed ID: 1645571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung.
    Pollard EB; Tio F; Myers JW; Clark G; Coltman CA; Von Hoff DD
    Cancer Res; 1981 Mar; 41(3):1015-20. PubMed ID: 6257379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.